GRIN2B and gastric cancer: The expression of 12 more biomarkers is associated with the pathological mechanism of gastric cancer, including VCAM-1, β-Catenin, c-Myc, CXCL13, DC-SIGN, EGFR, DAPK1, TIMP3, GRIN2B, SLC5A8, CDH1, and GATA-4.